Single heterozygous PARK2 or PARK6 mutations occur with similar frequency in patients with sporadic PD and healthy individuals; their estimated penetrance is around 1–25%, and their role in pathogenesis is still not well understood [45,46,47,48] (Figure 2B). The gene discussed is PRKN; the disease is Parkinson disease.